IQVIA REPORT. September 2021.

INFORME IQVIA
The data in this report are consistent with those of the HMR - Health Market Research Spain and Infonis International reports.

A good monthly performance that, although slowly, improves the annualized data, which continues to show that the sector is not recovering from the pandemic at the expected speed. Consistent with the general feel of the country's economy.

We will focus, as almost always, on #parapharmacy, especially the segment of dermopharmacy and diagnostic devices.

Regarding dermopharmacy, it is important to react quickly this fall. Competition increases (# M2C, franchises, food chains ...) and the #pharmacy should not fall asleep after a few months in which sales in this segment have not grown, except for solar, for obvious reasons. The autumn / winter season to be key in its reactivation

The same happens with the diagnostic devices, which seems to have preferred feeding channels and orthopedics to give them an outlet. We will dedicate a publication to it soon. It is a part of the business that should not be abandoned.

There are many product families that are still in stanby and must be activated again to meet the needs of niches that are going to other channels.

#BeFarmaPro, finding the alternatives offered by the market.

info@befarmapro.com

#pharmaceutical #gestionempresarial #bigdata #BeFarmaPro #bufetemarlopez #consultoria #mejoracontinua #leanmanagement #marketingestrategico #hmr #infonis #iqvia #fortefarma #xarxafarma #mdf

Deja un comentario